Statistics
Publications
8
Citations
240
H-Index
8
Active since
2018
Lirui Tang is an author at Fujian Medical University specializing in oncology, medicine, and prognostic factors analysis.
Publications per year
2018–2023
8
8
EZH2 Inhibitor Enhances the STING Agonist‒Induced Antitumor Immunity in Melanoma
Tianxiao Xu, Jie Dai, Lirui Tang et al. · Journal of Investigative Dermatology · 2021 · 30 citations · Full text
Medicine, Immunology, Oncology +12
1–5 of 8